SNOA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sonoma Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 1.14 USD -0.87%

Market Cap: $4m

	Sonoma Pharmaceuticals Inc NASDAQ:SNOA	US
	Komatsu Ltd TSE:6301	JP
	SBM Offshore NV AEX:SBMO	NL
T	Takashimaya Co Ltd SWB:TKM	JP
	Takashimaya Co Ltd F:TKM	JP
T	TUI AG XHAM:TUI1	DE
C	Compugen Ltd XBER:CW9	IL
	Abionyx Pharma SA F:609	FR
T	TC Energy Corp NYSE:TRP	CA
S	Site Centers Corp SWB:DDR2	US
	Site Centers Corp NYSE:SITC	US
	Nestle India Ltd NSE:NESTLEIND	IN
B	Bluebik Group PCL SET:BBIK	TH

Profitability Summary

Sonoma Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

38%

Sustainable 3Y Average Gross Margin

37%

Gross Margin is Increasing

35% > 38%

Negative Operating Margin

-13%

Negative 3Y Average Operating Margin

-29%

Operating Margin is Increasing

-37% > -13%

Negative Net Margin

-16%

Negative 3Y Average Net Margin

-31%

Net Margin is Increasing

-45% > -16%

Negative Free Cash Flow Margin

-21%

Negative 3Y Average Free Cash Flow Margin

-20%

Free Cash Flow Margin is Increasing

-40% > -21%

Negative ROE

-85%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-41%

ROIC is Increasing

-45% > -27%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.